|
AU1856997A
(en)
|
1996-02-02 |
1997-08-22 |
Merck & Co., Inc. |
Method for raising hdl cholesterol levels
|
|
US5663415A
(en)
|
1996-06-28 |
1997-09-02 |
Jame Fine Chemicals, Inc. |
Process for preparing antihistamine tannates
|
|
AR008789A1
(es)
|
1996-07-31 |
2000-02-23 |
Bayer Corp |
Piridinas y bifenilos substituidos
|
|
WO1999001423A1
(en)
|
1997-07-01 |
1999-01-14 |
Novo Nordisk A/S |
Glucagon antagonists/inverse agonists
|
|
US6613942B1
(en)
|
1997-07-01 |
2003-09-02 |
Novo Nordisk A/S |
Glucagon antagonists/inverse agonists
|
|
AU3033500A
(en)
|
1999-01-15 |
2000-08-01 |
Agouron Pharmaceuticals, Inc. |
Non-peptide glp-1 agonists
|
|
AU4537900A
(en)
|
1999-05-17 |
2000-12-05 |
Agouron Pharmaceuticals, Inc. |
Glucagon antagonists/inverse agonists
|
|
DE60039111D1
(de)
|
1999-09-28 |
2008-07-17 |
Bayer Corp |
Agonisten des rezeptors 3 (r3) von pituitary adenylate cyclase aktivierendem peptid (pacap) und ihre pharmakologische verwendung
|
|
EP2363396A1
(en)
|
2001-06-11 |
2011-09-07 |
Virochem Pharma Inc. |
Thiophene derivatives as antiviral agents for flavivirus infection
|
|
UA74912C2
(en)
|
2001-07-06 |
2006-02-15 |
Merck & Co Inc |
Beta-aminotetrahydroimidazo-(1,2-a)-pyrazines and tetratriazolo-(4,3-a)-pyrazines as inhibitors of dipeptylpeptidase for the treatment or prevention of diabetes
|
|
US20030083354A1
(en)
|
2001-10-26 |
2003-05-01 |
Pediamed Pharmaceuticals, Inc. |
Phenylephrine tannate and pyrilamine tannate salts in pharmaceutical compositions
|
|
US20030114535A1
(en)
|
2001-12-14 |
2003-06-19 |
Jame Fine Chemicals, Inc. |
Dextrochlorpheniramine tannate
|
|
US6670370B1
(en)
|
2001-12-14 |
2003-12-30 |
Jame Fine Chemicals, Inc. |
Dextromethorphan tannate
|
|
JO2625B1
(en)
*
|
2003-06-24 |
2011-11-01 |
ميرك شارب اند دوم كوربوريشن |
Phosphoric acid salts of dipeptidyl betidase inhibitor 4
|
|
CN100457108C
(zh)
|
2003-09-02 |
2009-02-04 |
默克公司 |
一种二肽基肽酶iv抑制剂的磷酸盐新晶体
|
|
WO2005030127A2
(en)
|
2003-09-23 |
2005-04-07 |
Merck & Co., Inc. |
Novel crystalline form of a phosphoric acid salt of a dipeptidyl peptidase-iv inhibitor
|
|
EP1708571A4
(en)
|
2004-01-16 |
2009-07-08 |
Merck & Co Inc |
NEW CRYSTALLINE SALTS OF A DIPEPTIDYLPEPTIDASE IV HEMMER
|
|
US20050202050A1
(en)
*
|
2004-03-12 |
2005-09-15 |
Kiel Jeffrey S. |
Single tank process for preparing tannate liquid and semi-solid dosage forms
|
|
WO2006033848A1
(en)
|
2004-09-15 |
2006-03-30 |
Merck & Co., Inc. |
Amorphous form of a phosphoric acid salt of a dipeptidyl peptidase-iv inhibitor
|
|
US20060270722A1
(en)
*
|
2005-05-31 |
2006-11-30 |
Thornberry Nancy A |
Combination of a dipeptidyl peptidase-IV inhibitor and a dual PPAR agonist for the treatment of diabetes and obesity
|
|
EP1909776A2
(en)
|
2005-07-25 |
2008-04-16 |
Merck & Co., Inc. |
Dodecylsulfate salt of a dipeptidyl peptidase-iv inhibitor
|
|
EP1942921A4
(en)
*
|
2005-10-25 |
2011-03-09 |
Merck Sharp & Dohme |
COMBINATION OF A DIPEPTIDYL-PEPTIDASE-4 HEMMER AND AN ANTIHYPERTENSIVE AGENT FOR THE TREATMENT OF DIABETES AND HYPERTONIA
|
|
UA97382C2
(ru)
*
|
2006-12-14 |
2012-02-10 |
Тева Фармасьютікл Індастріз, Лтд. |
Таннат разагилина
|
|
JP2011506442A
(ja)
*
|
2007-12-11 |
2011-03-03 |
コンジュケム バイオテクノロジーズ インコーポレイテッド |
インスリン分泌性ペプチド結合体の製剤
|
|
US8003672B2
(en)
*
|
2008-04-21 |
2011-08-23 |
Merck Sharp & Dohme Corp. |
CB-1 receptor modulator formulations
|
|
EP2218721A1
(en)
*
|
2009-02-11 |
2010-08-18 |
LEK Pharmaceuticals d.d. |
Novel salts of sitagliptin
|
|
US9211263B2
(en)
*
|
2012-01-06 |
2015-12-15 |
Elcelyx Therapeutics, Inc. |
Compositions and methods of treating metabolic disorders
|